Retrospective analysis assesses inflammation indicators for liver fibrosis prediction in patients with chronic hepatitis B, suggesting enhanced accuracy of the systemic immune inflammation index.
This study aims to investigate the values of related inflammation indicators in predicting the degree of liver fibrosis in patients with chronic hepatitis B (CHB). A 1-year retrospective study was conducted. The 120 CHB patients in the case group were divided into the non-fibrosis group (n = 26), mild-moderate fibrosis group (n = 34), severe fibrosis group (n = 27), and cirrhosis group (n = 33) based on the results of liver transient elastography. A total of 28 healthy individuals were included in the control group. Systemic immune inflammation index (SII), platelet-to-lymphocyte ratio (PLR), neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio, and monocyte-to-lymphocyte ratio were observed and compared. There was a significant correlation between liver fibrosis and SII, NLR, and PLR (P < .001), with the strongest correlation between liver fibrosis and SII (r = -0.952). With an area under the receiver operating characteristic curve of 0.982, an SII ≤ 353.605 had the best sensitivity accuracy (97.9%) for the detection of any grade of liver fibrosis. The 5 combined indicators had the highest specificity accuracy (96.2%). In limited-resource settings, the SII could serve as a new strategy for predicting the degree of liver fibrosis in CHB patients and was superior to the PLR and NLR.
No takes yet. Share an insight, caveat, or question.
Shen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: